Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 3, 2000, Pages 377-383

  Iroegbu, Johanna ^a   Birk, Markus ^a   Lazdina, Una ^a   Sönnerborg, Anders ^a   Sällberg, Matti ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAG PROTEIN; HLA ANTIGEN CLASS 1; HYBRID PROTEIN; NUCLEOTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANIMALS; BINDING SITES; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV CORE PROTEIN P24; HIV-1; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; PHYLOGENY; PLASMIDS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SEROLOGIC TESTS; SPECIES SPECIFICITY; VARIATION (GENETICS);

EID: 0034020064     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.3.377-383.2000     Document Type: Article

References (22)

1. Berkower, I., and J. Bridgewater. 1998. Genetic control of the immune response to HIV type 1 envelope glycoprotein 120 in mice: effects of MHC and transgenic human CD4. AIDS Res. Hum. Retrovir. 14:893-900.
2. Birk, M., J. I. Flock, A. Sönnerborg, and M. Sällberg. 1998. Coexisting members of the human immunodeficiency virus type-1 p17 gene quasispecies represent p17 proteins with distinct antigenicity and immunogenicity. AIDS 12:1973-1981.
3. Birk, M., A. Vahlne, A. Sönnerborg, and M. Sällberg. 1998. Non-synonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules. AIDS Res. Hum. Retrovir. 14:241-248.
4. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
5. gag protein. J. Virol. 67:694-702.
6. Connor, R. I., B. T. M. Korber, B. S. Graham, B. H. Hahn, D. D. Ho, B. D. Walker, A. U. Neumann, S. H. Vermund, J. Mestecky, S. Jackson, E. Fenamore, Y. Cao, F. Gao, S. Kalams, K. J. Kunstman, D. McDonald, N. McWilliams, A. Trkola, J. P. Moore, and S. M. Wolinsky. 1998. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J. Virol. 72:1552-1576.
7. Davis, H. L., M. L. Michel, M. Mancini, M. Schleef, and R. G. Whalen. 1994. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12:1503-1509.
8. Harrer, E., T. Harrer, S. Buchbinder, D. L. Mann, M. Feinberg, T. Yilma, R. P. Johnson, and B. D. Walker. 1994. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retrovir. 10(Suppl. 2):S77-S78.
9. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
10. Jassoy, C., R. P. Johnson, B. A. Navia, J. Worth, and B. D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
11. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
12. Kebede, T., S. Britton, T. Fehniger, A. Vahlne, and M. Sällberg. 1997. Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype. Clin. Diagn. Lab. Immunol. 4: 627-629.
13. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, et al. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1: 330-336.
14. Nakamura, Y., M. Kameoka, M. Tobiume, M. Kaya, K. Ohki, T. Yamada, and K. Ikuta. 1997. A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 gag protein. Vaccine 15:489-496.
15. Nietfield, W., M. Bauer, M. Fevrier, R. Maier, B. Holzwarth, R. Frank, B. Maier, Y. Riviere, and A. Meyerhans. 1995. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. J. Immunol. 154:2189-2197.
16. Preston, B. D., B. J. Poiesz, and L. A. Loeb. 1988. Fidelity of HIV-1 reverse transcriptase. Science 242:1168-1171.
17. Rosenberg, E. S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, and B. D. Walker. 1997. Vigorous HIV-1-specific Cd4(+) T cell responses associated with control of viremia. Science 278:1447-1450.
18. + cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens. J. Virol. 71:5295-5303.
19. Sällberg, M., Z. X. Zhang, M. Chen, L. Jin, A. Birkett, D. L. Peterson, and D. R. Milich. 1996. Immunogenicity and antigenicity of the ATPase/helicase domain of the hepatitis C virus non-structural 3 protein. J. Gen. Virol. 77: 2721-2728.
20. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283-1293.
21. Vaslin, B., J. M. Claverie, O. Benveniste, F. C. Barre-Sinoussi, and D. Dormont. 1994. Nef and gag synthetic peptide priming of antibody responses to HIV type 1 antigens in mice and primates. AIDS Res. Hum. Retrovir. 10: 1241-1250.
22. Zhang, Z. X., M. Chen, C. Hultgren, A. Birkett, D. R. Milich, and M. Sällberg. 1997. Immune responses to the hepatitis C virus NS4a are profoundly influenced by the combination of the viral genotype and the host major histocompatibility complex. J. Gen. Virol. 78:2735-2746.